Rationale During adolescence, the brain is maturing and more sensitive to drugs of abuse that can influence its developmental trajectory. Recently, attention has been focused on basic fibroblast growth factor (FGF-2) given that its administration early in life enhances the acquisition of cocaine selfadministration and sensitization at adulthood (Turner et al. (Pharmacol Biochem Behav 92:100-4, 2009), Clinton et al. (Pharmacol Biochem Behav103:6-17, 2012). Additionally, we found that abstinence from adolescent cocaine exposure long lastingly dysregulates FGF-2 transcription (Giannotti et al. (Psychopharmacology (Berl) 225:553-60, 2013 ). Objectives The objectives of the study are to evaluate if (1) a single injection of cocaine (20 mg/kg) at postnatal day 35 alters FGF-2 messenger RNA (mRNA) levels and (2) the first injection influences the trophic response to a second injection (10 mg/kg) provided 24 h or 7 days later. Results We found regional differences in the FGF-2 expression pattern as either the first or the second injection of cocaine by themselves upregulated FGF-2 mRNA in the medial prefrontal cortex and nucleus accumbens while downregulating it in the hippocampus. The first injection influences the trophic response of the second. Of note, 24 h after the first injection, accumbal and hippocampal FGF-2 changes produced by cocaine in saline-pretreated rats were prevented in cocaine-pretreated rats. Conversely, in the medial prefrontal cortex and hippocampus 7 days after the first injection, the cocaine-induced FGF-2 changes were modified by the subsequent exposure to the psychostimulant. Conclusions These findings show that a single cocaine injection is sufficient to produce enduring changes in the adolescent brain and indicate that early cocaine priming alters the mechanisms regulating the trophic response in a brain regionspecific fashion.
Introduction
During adolescence, the brain is still maturing and uniquely sensitive to drugs of abuse (Burke and Miczek 2014; Stanis and Andersen 2014) . Up to date, the mechanisms responsible for such higher vulnerability are still unknown. Given the role played by neurotrophic factors during critical windows of neurodevelopment, the possibility exists that perturbation of their expression or function could readily account for such vulnerability (McGinty et al. 2010; Thomas et al. 2008) . The roles of neurotrophic factors in brain development range from cell proliferation, migration, differentiation, and survival to synaptogenesis, myelination, and neuroprotection (Reichardt 2006) . However, and perhaps more important for sensitivity to drug abuse, since the functions of many of these factors overlap during development, we cannot expect that changes in their expression cause overt disorders but, rather, subtle defects that may impair, at least partially, brain homeostasis and neuroplasticity.
Several lines of evidence have been accumulated in the recent years on the potential contribution of one of such trophic factors, i.e. basic fibroblast growth factor (FGF-2), to such vulnerability. FGF-2 is the prototype member of a family of heparin-binding growth factors whose contribution to brain development has been extensively documented . We have previously contributed to demonstrate that FGF-2 is tightly involved in the programming of neural plasticity associated with less dramatic perturbations, such as prenatal stress or exposure to organophosphate (Slotkin et al. 2007 (Slotkin et al. , 2008 , suggesting that this trophic factor is sensitive to manipulations occurring early in life.
Indeed, FGF-2 might also represent a target of the early exposure to cocaine, a psychostimulant that acts primarily, but not solely, by increasing the extracellular levels of dopamine, via the blockage of the dopamine transporter (Rocha et al. 1998) . In fact, FGF-2 is expressed in the developing brain (Gomez-Pinilla et al. 1994; Monfils et al. 2006) , and it is modulated by dopamine (Fumagalli et al. 2003) . Further, when administered early in life, it potentiated the acquisition of cocaine self-administration (Turner et al. 2009 ) and enhanced cocaine sensitization at adulthood (Clinton et al. 2012) . In agreement with this hypothesis, we have recently shown that abstinence following adolescent exposure to cocaine leads to short-and long-term changes in FGF-2 gene expression in the rat brain . These data suggest that modulation of FGF-2 expression may be critical for the vulnerability of the adolescent brain to the action of cocaine.
However, the few studies on adolescent animals focused on repeated exposure to cocaine or on long-term withdrawal since the last drug administration Giannotti et al. 2014; Marin et al. 2008) . In our work, we decided to evaluate (1) whether, during brain development, an acute exposure to cocaine is sufficient to change the FGF-2 transcription and (2) whether the first injection influences the trophic factor response to a second injection. Accordingly, we exposed male rats to a first injection on postnatal day (PND) 35 followed by a second injection administered 24 h (PND 36) or 7 days later (PND 42). Taken together, the findings deriving from this two-hit approach will increase our knowledge on how drug abuse at adolescence might dynamically influence brain homeostasis, via changes in FGF-2-mediated trophic response.
Materials and methods

Materials
General reagents and molecular biology reagents were purchased from Applied Biosystem (Monza, Milan, Italy), BioRad Laboratories (Segrate, Milan, Italy) and Sigma (Milan, Italy). Cocaine hydrochloride was purchased from MacFarlan-Smith, Edinburgh, UK.
Animals and drug treatments
The animals used were generated by mating Sprague Dawley rats weighing 250 g (Charles River, Calco, Italy) and housed under standard conditions of temperature and humidity under artificial light (from 07:00 to 19:00 h). For each set of experiments, a maximum of two male siblings was taken from each litter in order to reduce "litter effects" (Chapman and Stern 1978) . Sprague Dawley male rats were exposed to the first intraperitoneal (i.p.) injection of cocaine (20 mg/kg) or saline at PND 35 and then challenged with a second i.p. injection of cocaine (10 mg/kg) or saline at PND 36, i.e. 24 h after the first one, or 7 days later at PND 42, during a period that roughly approximates adolescence in humans (Collins and Izenwasser 2004; Maldonado and Kirstein 2005) . Rats were sacrificed 2 h after the second injection.
At the scheduled time of sacrifice, brain regions of interest were immediately dissected, frozen on dry ice, and stored at −80°C. The medial prefrontal cortex (defined as Cg1, Cg3, and IL subregions) and the frontal cortex corresponding to plates 5-9 of the atlas of Paxinos and Watson (2005) were dissected from 2-mm thick slices; the nucleus accumbens (including NAc-shell and NAc-core subregions) corresponding to plates 9-13 was dissected from 2-mm thick slice (Paxinos and Watson 2005) . Hippocampus was grossly dissected from the whole brain.
The choice of these brain regions depended on their role in mediating the effects of cocaine: The nucleus accumbens mediates the acquiring of conditioned behaviors and plays a role in the increased sensitivity to drugs as addiction progresses; the medial prefrontal cortex modulates the emotional and motivational aspects of drug abuse; the hippocampus, instead, mediates drug-related changes in learning and memory.
Procedures involving animals and their care were conducted in conformity with institutional guidelines that are in compliance with national (D.L. n. 116, G.U., supplement 40, 18 Febbraio, 1992 , Circolare No. 8, G.U., 14 Luglio, 1994 and international laws and policies (EEC Council Directive 86/ 609, OJL 358, 1, December 12, 1987 ; Guide for the Care and Use of Laboratory Animals, National Academies Press, 8th Edition, 2011).
RNA preparation for analysis of FGF-2 mRNA levels by real-time RT PCR Total RNA was isolated and purified from the brain regions of interest as previously described . Following total RNA extraction, the samples were processed for real-time polymerase chain reaction (PCR) to assess messenger RNA (mRNA) levels, as previously described (Fumagalli et al. 2012) . Briefly, an aliquot of each sample was treated with DNase to avoid DNA contamination. RNA was analyzed by TaqMan qRT-PCR instrument (CFX384 realtime system, Bio-Rad Laboratories) using the iScript TM onestep RT-PCR kit for probes (Bio-Rad Laboratories). Samples were run in 384 well formats in triplicate as multiplexed reactions. Data were analyzed with the comparative threshold cycle (ΔΔCt) method using 36B4 as reference gene (Fumagalli et al. 2012 ). The following TaqMan Gene Expression Assay (Applied Biosystem) was used for FGF-2: ID Rn00570809_m1. The probe and primer sequences of for 36B4 were the following: forward primer 5′-TTCCCACTGG CTGAAAAGGT-3′, reverse primer 5′-CGCAGCCGCAAA TGC-3′, Probe 5′-AAGGCCTTCCTGGCCGATCCATC-3′. Thermal cycling was initiated with an incubation at 50°C for 10 min (RNA retrotranscription) and then at 95°C for 5 min (retrotranscriptase inactivation). After this initial step, 39 cycles of PCR were performed. Each PCR cycle consisted of heating the samples at 95°C for 10 s to enable the melting process and then for 30 s at 60°C for the annealing and extension reaction.
Statistical analysis
To determine treatment-related differences, we first subjected the values to a three-way analysis of variance (ANOVA), incorporating the following variables: first injection (saline vs cocaine), second injection (saline vs cocaine), and time between injections (24 h vs 7 days). As dictated by the relevant interaction terms, low-order ANOVAs were used to determine treatment effects and interactions followed by Fischer's protected least significant difference (Fisher's PLSD test) to characterize differences among individual values. Significance for all tests was assumed at p<0.05.
Results
Medial prefrontal cortex
In the medial prefrontal cortex (mPFC), three-way ANOVA revealed an effect of the first injection (F 1,45 =8.48, p=0.006) and a first injection×second injection interaction (F 1,45 =7.03, p=0.012) on FGF-2 mRNA levels (Fig. 1) . No significant effect of the time between injections was instead detected (F 1,45 =2.18, p=0.149). Thus, we made intergroup comparisons by two-way ANOVAs (first injection×second injection) for each group (i.e. animals challenged with cocaine 24 h and 7 days after the first injection). In the 24-h-challenged group, two-way ANOVA did not detect significant differences (first injection F 1,25 =1.23, p=0.280; second injection F 1,25 =0.181, p=0.68; first injection×second injection F 1,25 =2.30, p= 0.145). Conversely, in the 7-day-challenged group, we found effects of the first injection (F 1,20 =7.64, p=0.014) and a significant first injection × second injection interaction (F 1,20 =4.51, p=0.049). The post hoc analysis revealed that FGF-2 mRNA levels were increased 7 days after the first cocaine administration compared with the control group (+ 57 %, p=0.003, Fisher's PLSD test). In animals that were exposed to the first injection of cocaine, the second injection with the psychostimulant significantly decreased FGF-2 mRNA levels (−35 %, p=0.047, Fisher's PLSD test), an effect that was not observed in saline-pretreated animals (+14 %, p= 0.429).
Frontal cortex
In the frontal cortex, three-way ANOVA of FGF-2 found only an effect of the time between injections (F 1,48 =6.89, p=0.012) (first injection F 1,48 =0.556, p=0.460; second injection F 1,48 = 0.177, p=0.676), but the first injection of cocaine did not influence the trophic effects of the second injection (interaction between first injection×second injection×time between injections F 1,48 =0.014, p=0.905) (Fig. 2) . Accordingly, we did not subdivide the statistical analysis in this region.
Nucleus accumbens
Unlike the findings for the frontal cortex, in the nucleus accumbens (NAc), three-way ANOVA revealed effects of the second injection (F 1,47 =13.59, p=0.001), first injection× second injection interaction (F 1,47 =5.68, p=0.022) and first injection×second injection×time between injection interaction (F 1,47 =4.58, p=0.039) (Fig. 3) . Examining the individual treatment effects, we found that a single cocaine injection increased FGF-2 mRNA levels 24 h later (+28 % vs Sal35-Sal36, p=0.010, Fisher's PLSD test), an effect that returned to control level 7 days after the single cocaine injection (+5 % vs Sal35-Sal42, p=0.682, Fisher's PLSD test). The response to the second cocaine injection was different in saline-and cocaine-pretreated animals when challenged 24 h later. In fact, the cocaine-induced increase in FGF-2 mRNA levels observed in saline-pretreated rats (+36 % vs Sal35-Sal36, p= 0.001, Fisher's PLSD test) was prevented in cocainepretreated animals (−15 % vs Coc35-Sal36, p = 0.203, Fisher's PLSD test). On the other hand, when measured 7 days later, the second injection of cocaine induced an increase independently of the pretreatment. In fact, FGF-2 mRNA levels were increased in both the saline-(+32 % vs Sal35-Sal42, p=0.004, Fisher's PLSD test) and cocaine-pretreated rats (+29 % vs Coc35-Sal42, p=0.025, Fisher's PLSD test). Figure 4 shows the mRNA levels of FGF-2 in the hippocampus. In this brain region, three-way ANOVA revealed only a significant effect of the first injection×second injection interaction (F 1,45 =11.89, p=0.001) (first injection F 1,45 =3.83, p= 0.058; second injection F 1,45 =0.216, p=0.645; time between injections F 1,45 =2.39, p=0.131; interaction between first injection×second injection×time between injections F 1,45 = 0.657, p=0.423). Examining the individual treatment effects, lower order ANOVAs (first injection×second injection) were performed for each group (24 h and 7 day challenged). Rats that received the second injection 24 h later showed a significant effect of the second injection (F 1,23 =8.66, p=0.008) and a first injection × second injection interaction (F 1,23 = 4.48, p=0.048). Twenty-four hours after the first cocaine injection, FGF-2 was significantly reduced (−22 % vs Sal35-Sal36, p=0.038, Fisher's PLSD test). The second injection of cocaine caused a decrease in FGF-2 mRNA levels in salinepretreated rat (−37 % vs Sal35-Sal36, p=0.001, Fisher's PLSD test) but did not further reduce the FGF-2 levels in cocaine-pretreated rats (−6 % vs Coc35-Sal36, p=0.591, Fisher's PLSD test). Two-way ANOVA performed on the 7-day-challenged group showed an effect of the second injection (F 1,22 =8.51, p=0.009) and a first injection×second injection interaction (F 1,22 =7.30, p=0.015). FGF-2 mRNA levels were reduced 7 days after the first cocaine injection (−42 % vs Sal35-Sal42, p=0.007, Fisher's PLSD test). Cocaine challenge did not alter FGF-2 levels in saline-pretreated animals (+2 % vs Sal35-Sal42, p=0.873, Fisher's PLSD test), but the Fig. 1 Effects of a single injection of cocaine during brain development on FGF-2 mRNA levels in the rat medial prefrontal cortex: modulation by a second cocaine injection. Adolescent male rats (PND 35) were exposed to a first injection of cocaine (20 mg/kg) or saline at PND 35; then, each group was divided in four different groups receiving, respectively, cocaine (10 mg/kg) or saline at PND 36 or PND 42. Rats were sacrificed 2 h after the second injection with cocaine or saline. The results, expressed as % of SalineP35/SalineP36 rats, represent the mean±S.E.M. of at least five independent determinations; ** p<0.01 versus SalineP35/SalineP42 rats; # p<0.05 versus CocaineP35/CocaineP42 rats (two-way ANOVA followed by Fisher's PLSD test). Global ANOVA analysis appears in the upper box Fig. 2 Effects of a single injection of cocaine during brain development on FGF-2 mRNA levels in the rat frontal cortex: modulation by a second cocaine injection. Adolescent male rats (PND 35) were exposed to a first injection of cocaine (20 mg/kg) or saline at PND 35; then, each group was divided in four different groups receiving, respectively, cocaine (10 mg/kg) or saline at PND 36 or PND 42. Rats were sacrificed 2 h after the second injection with cocaine or saline. The results, expressed as % of SalineP35/SalineP36 rats, represent the mean±S.E.M. of at least five independent determinations. Global ANOVA analysis appears in the upper box second cocaine injection significantly increased FGF-2 levels in cocaine-pretreated rats (+52 % vs Coc35-Sal42, p=0.001, Fisher's PLSD test).
Hippocampus
Discussion
Our data reveal that a single exposure to cocaine during brain development is sufficient to alter FGF-2 mRNA levels in the rat brain for, at least, 7 days. Additionally, our results show that a single exposure to cocaine, during the sensitive period of adolescence, influences the response to a second dose of the psychostimulant suggesting that cocaine priming may have altered the mechanisms regulating the trophic response.
Indeed, we found regional differences in the FGF-2 response as either the first or the second injection of cocaine by themselves upregulated FGF-2 mRNA in the mPFC and NAc while downregulating it in the hippocampus. However, while the effect of the first injection of cocaine may be read as the acute response to cocaine, the effect brought about by the second injection, independently from the timing of the second challenge, illustrates the alteration of cell responsiveness following a cocaine-induced priming.
The analysis of the single injection of cocaine revealed a brain region-dependent profile. In the mPFC, FGF-2 mRNA Fig. 3 Effects of a single injection of cocaine during brain development on FGF-2 mRNA levels in the rat nucleus accumbens: modulation by a second cocaine injection. Adolescent male rats (PND 35) were exposed to a first injection of cocaine (20 mg/kg) or saline at PND 35; then, each group was divided in four different groups receiving, respectively, cocaine (10 mg/kg) or saline at PND 36 or PND 42. Rats were sacrificed 2 h after the second injection with cocaine or saline. The results, expressed as % of SalineP35/SalineP36 rats, represent the mean±S.E. p<0.01 versus CocaineP35/CocaineP42 rats (two-way ANOVA followed by Fisher's PLSD test) levels were increased 7 days after a single injection of cocaine while no effects were observed 24 h later, revealing a quite lasting effect promoted by the acute psychostimulant administration. In the NAc, baseline FGF-2 mRNA levels were increased 24 h after a single injection of cocaine while returning back to control levels 7 days later. Although different in terms of temporal induction of the effect, the accumbal and cortical FGF-2 upregulation may represent a homeostatic, protective response to oppose to cocaine-induced increase in neuronal activity and maintain cell homeostasis.
In the hippocampus, a single injection of cocaine reduced FGF-2 mRNA levels, when measured 24 h later, an effect that became more consistent 7 days later. This suggests that cocaine markedly reduces the hippocampal trophic response during adolescence, an effect that we did not observe at adulthood (Fumagalli et al. 2006) . Such reduction might be functionally relevant. In fact, a deficit of FGF-2 expression causes defects in hippocampal neurogenesis, an effect that seems to be critical for relapse (Deschaux et al. 2012) . Further, the reduction observed 7 days after the first exposure to cocaine might impair working memory, as shown by Sudai and colleagues following a similarly high dosage of cocaine (Sudai et al. 2011) . Notably, since a single injection of cocaine is sufficient to induce anxiety in rats (Kohtz et al. 2010) , an effect that has been linked to lower levels of hippocampal FGF-2 (Eren- Kocak et al. 2011; Turner et al. 2011) , our data suggest that reduced FGF-2 levels in the hippocampus may represent a sign of vulnerability for cocaine-induced anxiety: This observation is intriguing since it appears that, during adolescence, acute psychostimulant exposure recapitulates anxiety-like behaviors that are usually only seen following chronic mild stress (Kompagne et al. 2008) . Further experiments will explore the potential relevance of such reduction to psychiatric-like disorders.
A further degree of interest highlighted by our results is the observation that, in a brain region-dependent fashion, the first injection of cocaine has altered the trophic response to a second injection. Of note, in the NAc and hippocampus (24 h) as well as in the mPFC (7 days), the physiological rise of FGF-2 mRNA levels following acute exposure to cocaine is prevented in cocaine-primed animals whereas in the hippocampus (7 days), we observed a marked increase of FGF-2 mRNA levels in cocaine-primed animals that was absent in animals that received the first injection of saline. Whatever the functional relevance, these results clearly indicate that cocaine priming during adolescence has profoundly dysregulated the adaptive trophic response.
We are aware that some limitations exist regarding our approach, which relies on mRNA level measurement that by itself does not represent a definitive answer about the real rate of synthesis and degradation of the protein. However, the reliability and reproducibility of the commercially available antibodies is questionable, whereas real-time PCR is widely recognized as a reliable and reproducible technique.
In conclusion, our results show that FGF-2 is likely to be a prominent target for the developmental neurotoxicity of cocaine. The evidence that the first exposure to cocaine influences the trophic response to a second injection highlights the dynamic, perhaps maladaptive, nature of the mechanisms set into motion by the early exposure to the psychostimulant. Given the neuroprotective and neuroplastic role played by FGF-2 in the brain, we favor the possibility that cocaineinduced increase of FGF-2 mRNA levels as observed in the NAc and mPFC might be protective whereas, in the hippocampus, it may represent a factor of vulnerability, perhaps predisposing to anxiety following a week of drug withdrawal. Based on these data, we suggest that manipulations aimed at restoring FGF-2 expression could ameliorate at least some aspects of the developmental effects brought about by cocaine.
